GL1X · GenesisL1 explorer

UniProt Q99986

Serine/threonine-protein kinase VRK1 (Q99986)

Serine/threonine-protein kinase VRK1 (UniProt Q99986), EC 2.7.11.1: 36 experimental structures on GenesisL1, 23 ligands bound, 72 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.

UniProt
Q99986
Protein
Serine/threonine-protein kinase VRK1
EC
2.7.11.1
Experimental structures
36
Predicted models
0
Ligands
23
Pockets
72 · 5 records with a druggable one

Structures

36 records of Q99986 in the MolNFT archive: 36 experimental, 0 predicted.

EntryTitleMethodChainsLigandsPockets
2KTYSolution Structure of human Vaccinia Related Kinase-1solution nmrA——
2KTYSolution structure of human vaccinia related kinase-1solution nmrA——
2KULSolution structure of human vaccinia related kinase 1(VRK1)solution nmrA——
2KULSolution structure of human vaccinia related kinase 1(VRK1)solution nmrA——
2LAVNMR solution structure of human Vaccinia-Related Kinase 1solution nmrA——
2LAVNMR solution structure of human vaccinia-related kinase 1solution nmrA——
2RSVSolution structure of human full-length vaccinia related kinase 1 (VRK1)solution nmrA——
2RSVSolution structure of human full-length vaccinia related kinase 1 (VRK1)solution nmrA——
3OP5Human vaccinia-related kinase 1x-ray diffractionA, B, C, D——
3OP5Human vaccinia-related kinase 1x-ray diffractionA, B, C, D——
5UKFCrystal structure of the human vaccinia-related kinase 1 bound to an oxindole inhibitorx-ray diffractionA, B, C, D8E1, PO4, CL—
5UVFCrystal structure of the human vaccinia-related kinase bound to bi- D1870x-ray diffractionA, B, C, D7DZ, PO4, CL—
6AC9Crystal structure of human vaccinia-related kinase 1 (VRK1) in complex with AMP-pnpx-ray diffractionA, B, C, DANP, MG, SO4, CL—
6BP0Crystal Structure of the Human vaccinia-related kinase 1 bound to (R)-2-phenylaminopteridi inhibitorx-ray diffractionA, B, C, DCL, E1D, SO414 (best 0.71)
6BP0Crystal structure of the human vaccinia-related kinase 1 bound to (R)- 2-phenylaminopteridinone…x-ray diffractionA, B, C, DCL, E1D, SO4—
6BRUCrystal structure of the human vaccinia-related kinase bound to a (S)- 2-phenylaminopteridinone…x-ray diffractionA, B, C, DSO4, E5M—
6BTWCrystal Structure of the Human vaccinia-related kinase bound to a phenyl-pteridi inhibitorx-ray diffractionA, B, C, DCL, E8D, SO415 (best 0.71)
6BTWCrystal structure of the human vaccinia-related kinase bound to a phenyl-pteridinone inhibitorx-ray diffractionA, B, C, DCL, E8D, SO4—
6BU6Crystal structure of the human vaccinia-related kinase bound to a bis- difluorophenol-aminopyridine…x-ray diffractionA, B, C, DE8V, CL, SO4—
6CFMCrystal structure of the human vaccinia-related kinase bound to a propynyl-pteridinone inhibitorx-ray diffractionA, B, C, DEA7, CL—
6CMMCrystal structure of the human vaccinia-related kinase bound to a N,N- dipropynyl-dihydropteridine…x-ray diffractionA, B, C, DF7D, SO4—
6CNXCrystal structure of the human vaccinia-related kinase 1 (VRK1) bound to an…x-ray diffractionA, B, C, DF87, SO4, FCS—
6CQHCrystal Structure of the Human vaccinia-related kinase bound to a…x-ray diffractionA, B, C, DF8Y, SO4, CL—
6CQHCrystal structure of the human vaccinia-related kinase bound to a N…x-ray diffractionA, B, C, DF8Y, SO4, CL—
6CSWCrystal structure of the human vaccinia-related kinase bound to a N…x-ray diffractionA, B, C, DSO4, FBY, CL—
6DD4Crystal structure of the human vaccinia-related kinase bound to a N,N- dipropyl-dihydropteridine…x-ray diffractionA, B, C, DCL, G6J, SO4—
6NPNCrystal Structure of the Human vaccinia-related kinase bound to a…x-ray diffractionA, B, C, DKWJ, SO414 (best 0.72)
6NPNCrystal structure of the human vaccinia-related kinase bound to a N,N…x-ray diffractionA, B, C, DKWJ, SO4—
6VXUStructure of Human Vaccinia-related Kinase 1 (VRK1) bound to ACH471x-ray diffractionA, B, C, DRTJ, SO4, VBD12 (best 0.70)
6VXUStructure of human vaccinia-related kinase 1 (VRK1) bound to ACH471x-ray diffractionA, B, C, DRTJ, SO4, VBD—
6VZHStructure of human vaccinia-related kinase 1 (VRK1) bound to LDSM311x-ray diffractionA, B, C, DSO4, RYA—
7M10PHF2 phd domain complexed with peptide from N-terminus of VRK1x-ray diffractionB——
7TANStructure of VRK1 C-terminal tail bound to nucleosome core particleelectron microscopyK, L——
7TANStructure of VRK1 C-terminal tail bound to nucleosome core particleelectron microscopyK, L——
8V42Structure of Human Vaccinia-related Kinase 1 (VRK1) Bound to ACH000400x-ray diffractionA, B, C, DYD9, SO417 (best 0.70)
Q99986AlphaFold monomer V2.0 prediction for SERINE/THREONINE-protein kinase VRK1 (Q99986)———

Ligands

  • SO4 · Sulfate ion · in 19 records
  • CL · Chloride ion · in 13 records
  • E1D · (7R)-2-[(3,5-difluoro-4-hydroxyphenyl)amino]-5,7,8-trimethyl-7,8-dihydropteridin-6(5H)-one · in 2 records
  • E8D · 2-[(3,5-difluoro-4-hydroxyphenyl)amino]-8-phenyl-7,8-dihydropteridin-6(5H)-one · in 2 records
  • F8Y · (7R)-2-[(3,5-difluoro-4-hydroxyphenyl)amino]-8-ethyl-7-methyl-5-(prop-2-yn-1-yl)-7,8-dihydropteridin-6(5H)-one · in 2 records
  • KWJ · (7R)-7-methyl-2-[(3-oxo-2,3-dihydro-1H-indazol-6-yl) amino]-5,8-di(prop-2-yn-1-yl)-7,8-dihydropteridin-6(5H)-one · in 2 records
  • PO4 · Phosphate ion · in 2 records
  • RTJ · (7R)-8-(cyclopropylmethyl)-2-[(3,5-difluoro-4-hydroxyphenyl)amino]-7-methyl-5-(prop-2-yn-1-yl)-7,8-dihydropteridin-6(5H)-one · in 2 records
  • VBD · (7S)-8-(cyclopropylmethyl)-2-[(3,5-difluoro-4-hydroxyphenyl)amino]-7-methyl-5-(prop-2-yn-1-yl)-7,8-dihydropteridin-6(5H)-one · in 2 records
  • 7DZ · (7S)-2-[(3,5-difluoro-4-hydroxyphenyl)amino]-5,7-dimethyl-8-(3-methylbutyl)-7,8-dihydropteridin-6(5H)-one · in 1 record
  • 8E1 · 4-{[(Z)-(7-oxo-6,7-dihydro-8H-[1,3]thiazolo[5,4-e]indol-8-ylidene)methyl]amino}benzene-1-sulfonamide · in 1 record
  • ANP · Phosphoaminophosphonic acid-adenylate ester · in 1 record
  • E5M · (7S)-2-[(3,5-difluoro-4-hydroxyphenyl)amino]-5,7,8-trimethyl-7,8-dihydropteridin-6(5H)-one · in 1 record
  • E8V · 4,4'-(2-aminopyridine-3,5-diyl)bis(2,6-difluorophenol) · in 1 record
  • EA7 · (7R)-2-[(3,5-difluoro-4-hydroxyphenyl)amino]-7,8-dimethyl-5-(prop-2-yn-1-yl)-7,8-dihydropteridin-6(5H)-one · in 1 record
  • F7D · (7R)-2-[(3,5-difluoro-4-hydroxyphenyl)amino]-7-methyl-5,8-di(prop-2-yn-1-yl)-7,8-dihydropteridin-6(5H)-one · in 1 record
  • F87 · (7R)-2-[(3,5-difluoro-4-hydroxyphenyl)amino]-7-methyl-8-(3-methylbutyl)-5-(prop-2-yn-1-yl)-7,8-dihydropteridin-6(5H)-one · in 1 record
  • FBY · (7R)-5-butyl-2-[(3,5-difluoro-4-hydroxyphenyl)amino]-7, 8-dimethyl-7,8-dihydropteridin-6(5H)-one · in 1 record
  • FCS · (7S)-2-[(3,5-difluoro-4-hydroxyphenyl)amino]-7-methyl-8-(3-methylbutyl)-5-(prop-2-yn-1-yl)-7,8-dihydropteridin-6(5H)-one · in 1 record
  • G6J · (7R)-2-[(3,5-difluoro-4-hydroxyphenyl)amino]-7-methyl-5,8-dipropyl-7,8-dihydropteridin-6(5H)-one · in 1 record
  • MG · Magnesium ion · in 1 record
  • RYA · (7~{R})-2-[[3,5-bis(fluoranyl)-4-oxidanyl-phenyl]amino]-5,7-dimethyl-8-prop-2-ynyl-7~{H}-pteridin-6-one · in 1 record
  • YD9 · (7S)-2-(3,5-difluoro-4-hydroxyanilino)-7-methyl-5-[(1,2-oxazol-5-yl)methyl]-8-(prop-2-yn-1-yl)-7,8-dihydropteridin-6(5H)-one · in 1 record

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.